These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 27741115)

  • 1. Case report and literature review: Glomerular and neurologic thrombotic microangiopathy as a primary manifestation of multicentric castleman disease.
    Flahault A; Vignon M; Rabant M; Hummel A; Noël LH; Canioni D; Knebelmann B; Suarez F; El Karoui K
    Medicine (Baltimore); 2016 Oct; 95(41):e5047. PubMed ID: 27741115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successfully treated multicentric Castleman's disease with renal thrombotic microangiopathy using rituximab and corticosteroid.
    Lee JP; Kim DK; Oh DY; Paik JH; Moon KC; Kim S; Kim YS
    Clin Nephrol; 2011 Feb; 75(2):165-70. PubMed ID: 21255547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal failure in pediatric Castleman disease: Four French cases with thrombotic microangiopathy.
    Cousin E; Flodrops H; Boyer O; Hogan J; Ruin M; Couderc A; Goujon JM; Taque S
    Pediatr Blood Cancer; 2018 Jul; 65(7):e27045. PubMed ID: 29603588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kidney biopsy findings in two patients with TAFRO syndrome: case presentations and review of the literature.
    Zhou Q; Zhang Y; Zhou G; Zhu J
    BMC Nephrol; 2020 Nov; 21(1):499. PubMed ID: 33225930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal Pathologic Findings in TAFRO Syndrome: Is There a Continuum Between Thrombotic Microangiopathy and Membranoproliferative Glomerulonephritis? A Case Report and Literature Review.
    Leurs A; Gnemmi V; Lionet A; Renaud L; Gibier JB; Copin MC; Hachulla E; Hatron PY; Launay D; Fajgenbaum D; Terriou L
    Front Immunol; 2019; 10():1489. PubMed ID: 31316523
    [No Abstract]   [Full Text] [Related]  

  • 6. Unexplained cause of thrombocytopenia, fever, anasarca and hypothyroidism: TAFRO syndrome with thrombotic microangiopathy renal histology.
    Simeni Njonnou SR; Deuson J; Royer-Chardon C; Vandergheynst FA; Wilde V
    BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32606113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TAFRO Syndrome with Renal Thrombotic Microangiopathy: Insights into the Molecular Mechanism and Treatment Opportunities.
    Tu KH; Fan PY; Chen TD; Chuang WY; Wu CY; Ku CL; Tian YC; Yang CW; Fang JT; Yang HY
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rare case of renal thrombotic microangiopathy associated with Castleman's disease.
    Mutneja A; Cossey LN; Liapis H; Chen YM
    BMC Nephrol; 2017 Feb; 18(1):57. PubMed ID: 28183278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Siltuximab Monotherapy in Tafro Syndrome: A Case Report and Review of the Literature.
    Cordero L; Aguilar-Rodríguez F; Sandino J; Alonso M; Gutiérrez E
    J Nephrol; 2023 May; 36(4):1181-1185. PubMed ID: 36652167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TAFRO syndrome as a cause of glomerular microangiopathy: a case report and literature review.
    Nagayama Y; Yamano M; Yagame M; Nariyama T; Takahashi M; Kawamoto M; Matsui K
    BMC Nephrol; 2019 Oct; 20(1):375. PubMed ID: 31623576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal thrombotic microangiopathy associated with multicentric Castleman's disease. Report of two cases.
    Lajoie G; Kumar S; Min KW; Silva FG
    Am J Surg Pathol; 1995 Sep; 19(9):1021-8. PubMed ID: 7661275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombotic microangiopathy on kidney biopsy in a patient with TAFRO syndrome.
    Ozeki T; Tsuji M; Yamamoto J; Shigematsu C; Maruyama S
    CEN Case Rep; 2018 Nov; 7(2):243-247. PubMed ID: 29766467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thrombotic microangiopathy developing subsequent to tocilizumab therapy in a patient with TAFRO syndrome].
    Ito S; Tsutsumi Y; Kikuchi R; Matsuoka S; Shimoyama N
    Rinsho Ketsueki; 2018; 59(11):2432-2437. PubMed ID: 30531139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postpartum thrombotic microangiopathy revealed as atypical hemolytic uremic syndrome successfully treated with eculizumab: a case report.
    Kourouklaris A; Ioannou K; Athanasiou I; Panagidou A; Demetriou K; Zavros M
    J Med Case Rep; 2014 Sep; 8():307. PubMed ID: 25219386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membranous nephropathy with thrombotic microangiopathy-like lesions successfully treated with tocilizumab in a patient with idiopathic multicentric Castleman disease.
    Tosaki T; Okabe M; Suzuki T; Shimizu A; Koike K; Tsuboi N; Kawamura T; Ohashi R; Yano S; Yokoo T
    CEN Case Rep; 2021 May; 10(2):265-272. PubMed ID: 33389670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of TAFRO syndrome, a variant type of multicentric Castleman disease with thrombotic microangiopathy, with anti-IL-6 receptor antibody and steroids.
    Fujiwara S; Mochinaga H; Nakata H; Ohshima K; Matsumoto M; Uchiba M; Mikami Y; Hata H; Okuno Y; Mitsuya H; Nosaka K
    Int J Hematol; 2016 Jun; 103(6):718-23. PubMed ID: 26980221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment with tocilizumab for refractory anemia and slowly progressive renal glomerulosclerosis in multicentric Castleman disease: A case report.
    Sugawara E; Sato T; Amasaki Y; Katsumata K
    Medicine (Baltimore); 2022 Feb; 101(8):e28941. PubMed ID: 35212301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal histology in a patient with TAFRO syndrome: a case report.
    Mizuno H; Sekine A; Oguro M; Oshima Y; Kawada M; Sumida K; Yamanouchi M; Hayami N; Suwabe T; Hiramatsu R; Hasegawa E; Hoshino J; Sawa N; Fujii T; Takaichi K; Ohashi K; Ubara Y
    Hum Pathol; 2018 Dec; 82():258-263. PubMed ID: 29626596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid Clinical Improvement of Multicentric Castleman Disease (MCD) with Renal Involvement Following Treatment with Tocilizumab: AA Amyloidosis as a Possible Renal Involvement of MCD.
    Temmoku J; Sasajima T; Kuroda T; Sumichika Y; Saito K; Yoshida S; Matsumoto H; Fujita Y; Matsuoka N; Asano T; Sato S; Yamada T; Hashimoto Y; Migita K
    Tohoku J Exp Med; 2023 Mar; 259(4):285-291. PubMed ID: 36653160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HHV-8-negative multicentric Castleman disease presenting as a crescentic immune complexes membranoproliferative glomerulonephritis.
    Nunes MB; Rotman S; Duss FR; Halfon M
    BMJ Case Rep; 2020 Jan; 13(1):. PubMed ID: 31911409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.